1.0
OBJECTIVE:
SCOPE:
This SOP shall be applicable to all
the Master Formula Record Preparation and reviews in --------------------
3.0
RESPONSIBILITY:
3.1
Primary responsibility: F&D and Production
Department personnel.
3.2
Secondary responsibility: Quality Assurance
Department.
4.0
ACCOUNTABILITY:
4.1
HEAD
– QA shall be accountable for implementation and complies of this SOP.
5.0
PROCEDURE:
5.1
Production
Department in association with F&D, shall prepare Master Formula Record
(MFR).
5.2
Master
Formula Record (MFR) shall be prepared as per the format attached to this SOP.
5.3
Master
Formula Record (MFR) shall be divided into two parts as shown in the attached
Format - Manufacturing part and Packaging part.
5.4
The
first page of both the sections shall have following details:
5.4.1
Name,
Address and Logo of the Company.
5.4.2
Dosage
Form:
5.4.3
Brand
Name:
5.4.4
Generic
Name:
5.4.5
Product
Code:
5.4.6
Label
claim: This should include all ingredients and text included in product
permission.
5.4.7
Product
description:
5.4.8
Batch
Size:
5.4.9
Pack
size: This should describe the packing style of salable pack and sample pack.
This should be expressed in terms of the number, weight or volume of the
product in the final container.
5.4.10 Shelf life:
5.4.11 Storage condition:
5.4.12 Drug schedule: Whether schedule
"H" or schedule "G" drug.
5.4.13 Superseded Master Card No. and
date:
5.4.14 Present Master Card No. and date:
5.4.15 Present Master Card effective Batch.
No.:
5.4.16 Reference of change control
number:
5.5
There
shall be authorization on all pages of Master Formula Record (MFR) by three
persons i.e. person who shall prepare the Master Formula Record (Production
Officer), the person who shall check the Master Formula Record (Production
Head) and the person who shall finally approve(Quality Assurance Head) it. All
the three persons will sign off all the pages. Their designation and their name
will be printed below their signatures along with the date of signing the
document.
5.6
The
second page of manufacturing section shall include - Process steps to be
monitored.
5.7
Subsequent
pages shall include the processes to be monitored. The stage-wise movement of
the material in a form of flowchart. The flow chart shall cover all activities
beginning from the dispensing of the materials and ending at the transfer of a
batch to finished stores.
5.8
The
list of equipment, machines, utensils to be used, shall be described.
5.9
The
subsequent page shall include any special precautions to be taken for the
product during manufacturing and packing. The same page should also include
Batch Manufacturing Formula. The batch formula should have following columns:
5.9.1
Serial
number
5.9.2
Name
of ingredients
5.9.3
Reference
of the specification of ingredients
5.9.4
Quantity
to be added (in mg per ml or per tablet or per capsule or per gram as the case
may be)
5.9.5
Overages
to be added (in %)
5.9.6
Quantity
to be added per batch or per lot
5.10
Below
that give the calculation steps for every active material, ensuring that the
active materials shall be compensated for assay values less than 100 % which
could be due to less potency or higher moisture content.
5.11
In
subsequent page, include manufacturing process. Write the process stage wise
and stepwise. At the end of every important stage, include a statement of the yield with
acceptable limits.
5.12
Include
in-process quality checks during and at the end of important steps and stages
with their limits.
5.13
The
process shall include the process equipment to be used. The methods or the
reference of the methods/ procedures to be employed for preparing, cleaning,
assembling, operating the various equipment shall be given.
5.14
Include
detailed stepwise processing instructions (e.g. checks on materials,
pretreatments, the sequence for adding materials, mixing times, temperatures,
humidity etc.).
5.15
Include
the requirements for storage conditions of the products.
5.16
The
packing part of Master Formula Record (MFR) should include a complete list of
all the packaging materials required for a standard batch size, including
quantities, sizes and types.
5.17
Include
line clearance checking during batch coding and batch packing operations.
5.18
Include
reconciliation of printed and unprinted packing materials with acceptable
limits.
5.19
Include
destruction of excess or rejected printed packing materials.
5.20
Include
description of packaging operation including any significant subsidiary
operations and equipment to be used. Include details of in-process controls
with instructions for sampling and acceptance limits.
5.21
Include
reconciliation of the packing yield with acceptable limits.
5.22
Finally
include batch release procedure.
6.0
LIST OF ANNEXURE AND FORMATS:
Sr. No. |
Title of Format |
Format No. |
1.
|
F/XX-YYY-00 |
RX |
7.0
REFERENCE:
7.1 SOP-QA-001
7.2 F/QA-001-01
7.3 SOP-QA-004
7.4 SOP-QA-024
REVISION HISTORY:
Sr. No. |
Date |
Reason for Revision |
Revision No |
1.
|
31/10/2018 |
New
SOP |
R0 |
2.
|
31/10/2020 |
Schedule
Revision |
R1 |
9.0
ABBREVIATIONS:
Sr. No |
Abbreviations |
Details |
|
SOP |
Standard operating procedure |
|
No. |
Number |
|
QA |
Quality assurance |
|
IPQA |
In process quality assurance |
|
QC |
Quality control |
|
e.g. |
Example |
END OF
DOCUMENT
No comments:
Post a Comment
Pharmaceutical guideline only